IFNG and Alzheimer disease: By inhibiting the inflammatory responses mediated by cytokines like TNF-α, IFN-γ, and IL-6, it may be possible to mitigate the neuroinflammatory processes that contribute to AD pathology (Jiang et al. 2019; Dhapola et al. 2021).